These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 3973964)

  • 1. Protective effects of glycoprotein-specific monoclonal antibodies on the course of experimental mumps virus meningoencephalitis.
    Wolinsky JS; Waxham MN; Server AC
    J Virol; 1985 Mar; 53(3):727-34. PubMed ID: 3973964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentiation of mumps virus strains with monoclonal antibody to the HN glycoprotein.
    Server AC; Merz DC; Waxham MN; Wolinsky JS
    Infect Immun; 1982 Jan; 35(1):179-86. PubMed ID: 6172379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibodies against the fusion protein are protective in necrotizing mumps meningoencephalitis.
    Löve A; Rydbeck R; Utter G; Orvell C; Kristensson K; Norrby E
    J Virol; 1986 Apr; 58(1):220-2. PubMed ID: 3754016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mumps virus infection of the developing mouse brain--appearance of structural virus proteins demonstrated with monoclonal antibodies.
    Kristensson K; Orvell C; Malm G; Norrby E
    J Neuropathol Exp Neurol; 1984 Mar; 43(2):131-40. PubMed ID: 6368757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The reactions of monoclonal antibodies with structural proteins of mumps virus.
    Orvell C
    J Immunol; 1984 May; 132(5):2622-9. PubMed ID: 6201553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemagglutinin-neuraminidase glycoprotein as a determinant of pathogenicity in mumps virus hamster encephalitis: analysis of mutants selected with monoclonal antibodies.
    Löve A; Rydbeck R; Kristensson K; Orvell C; Norrby E
    J Virol; 1985 Jan; 53(1):67-74. PubMed ID: 2578198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection of hamsters against experimental mumps virus (MuV) infection by antibodies raised against the MuV surface glycoproteins expressed from recombinant vaccinia virus vectors.
    Houard S; Varsanyi TM; Milican F; Norrby E; Bollen A
    J Gen Virol; 1995 Feb; 76 ( Pt 2)():421-3. PubMed ID: 7844562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is bivalent binding of monoclonal antibodies to different antigenic areas on the hemagglutinin of influenza virus required for neutralization of viral infectivity?
    Yoden S; Kida H; Yanagawa R
    Arch Virol; 1985; 85(3-4):209-16. PubMed ID: 2411245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selection of mutants of mumps virus with altered structure and pathogenicity by passage in vivo.
    Löve A; Rydbeck R; Ljungdahl A; Kristensson K; Norrby E
    Microb Pathog; 1986 Apr; 1(2):149-58. PubMed ID: 3508486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Localization of a new neutralizing epitope on the mumps virus hemagglutinin-neuraminidase protein.
    Cusi MG; Fischer S; Sedlmeier R; Valassina M; Valensin PE; Donati M; Neubert WJ
    Virus Res; 2001 Apr; 74(1-2):133-7. PubMed ID: 11226581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of serologically defined epitopes on mumps virus HN-glycoprotein in the induction of virus-dependent cell-mediated cytotoxicity. Analysis with monoclonal antibodies.
    Alsheikhly AR; Orvell C; Andersson T; Perlmann P
    Scand J Immunol; 1985 Nov; 22(5):529-38. PubMed ID: 2417309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Epitope analysis of mumps virus proteins in a persistent cell culture infection: changes in the hemagglutinin-neuraminidase polypeptide].
    Boriskin IuS; Bogomolova NN; Orvell C
    Vopr Virusol; 1988; 33(5):595-600. PubMed ID: 2464243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection against lethal viral infection by neutralizing and nonneutralizing monoclonal antibodies: distinct mechanisms of action in vivo.
    Lefrancois L
    J Virol; 1984 Jul; 51(1):208-14. PubMed ID: 6328040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutralizing F(ab')2 fragments of protective monoclonal antibodies to yellow fever virus (YF) envelope protein fail to protect mice against lethal YF encephalitis.
    Schlesinger JJ; Chapman S
    J Gen Virol; 1995 Jan; 76 ( Pt 1)():217-20. PubMed ID: 7844536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological relationships between mumps virus and parainfluenza viruses studied with monoclonal antibodies.
    Orvell C; Rydbeck R; Löve A
    J Gen Virol; 1986 Sep; 67 ( Pt 9)():1929-39. PubMed ID: 3018131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistence of neuroadapted mumps virus in brains of newborn hamsters after intraperitoneal inoculation.
    Wolinsky JS; Klassen T; Baringer JR
    J Infect Dis; 1976 Mar; 133(3):260-7. PubMed ID: 1254987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of viral glycoproteins in mumps virus-mediated antibody-dependent cellular cytotoxity in vitro.
    Alsheikhly AR; Orvell C; Wåhlin B; Andersson T; Perlmann P
    Scand J Immunol; 1984 Nov; 20(5):449-60. PubMed ID: 6209792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracellular maturation of mumps virus hemagglutinin-neuraminidase glycoprotein: conformational changes detected with monoclonal antibodies.
    Waxham MN; Merz DC; Wolinsky JS
    J Virol; 1986 Aug; 59(2):392-400. PubMed ID: 3735488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antibodies against the glycoproteins of mumps virus: fusion inhibition by anti-HN monoclonal antibody.
    Tsurudome M; Yamada A; Hishiyama M; Ito Y
    J Gen Virol; 1986 Oct; 67 ( Pt 10)():2259-65. PubMed ID: 3760826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mumps meningoencephalitis in Stockholm November 1964-July 1971. II. Isolation attemps from the cerebrospinal fluid in a hospitalized study group.
    Wolontis S; Bjorvatin B
    Scand J Infect Dis; 1973; 5(4):261-71. PubMed ID: 4780362
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.